Nononcological Applications of Positron Emission Tomography for Evaluation of the Thorax

Positron emission tomography is a powerful quantitative molecular imaging technique that is complementary to structural imaging techniques for purposes of disease detection and characterization. This review article provides an overview of the applications of positron emission tomography for evaluation of patients with nononcological diseases that may be encountered in the thorax, such as infection, sarcoidosis, idiopathic interstitial pneumonia, adult respiratory distress syndrome, chronic obstructive pulmonary disease, and atherosclerosis among others.

[1]  A. Aravkin,et al.  Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG. , 2011, AJR. American journal of roentgenology.

[2]  M. Mehta,et al.  The Impact of Hybrid PET-CT Scan on Overall Oncologic Management, with a Focus on Radiotherapy Planning: A Prospective, Blinded Study , 2009, Technology in cancer research & treatment.

[3]  M. Charron,et al.  Cystic fibrosis: detecting changes in airway inflammation with FDG PET/CT. , 2012, Radiology.

[4]  Abass Alavi,et al.  Positron emission tomography imaging in nonmalignant thoracic disorders. , 2002, Seminars in nuclear medicine.

[5]  A. Alavi,et al.  Etiopathologies Associated with Intercostal Muscle Hypermetabolism and Prominent Right Ventricle Visualization on 2-Deoxy-2[F-18]fluoro-d-glucose-Positron Emission Tomography: Significance of an Incidental Finding and in the Setting of a Known Pulmonary Disease , 2007, Molecular Imaging and Biology.

[6]  Paul Barnett,et al.  Cost-Effectiveness of Alternative Management Strategies for Patients with Solitary Pulmonary Nodules , 2003, Annals of Internal Medicine.

[7]  G. Antoch,et al.  Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  Hao Zhang,et al.  Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer. , 2012, Academic radiology.

[9]  A. Alavi,et al.  18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease Characterization* , 2009, Journal of Nuclear Medicine.

[10]  Tomio Inoue,et al.  Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  C. Sima,et al.  High SUVmax on FDG-PET Indicates Pleomorphic Subtype in Epithelioid Malignant Pleural Mesothelioma: Supportive Evidence to Reclassify Pleomorphic as Nonepithelioid Histology , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  Bruce D Cheson,et al.  Role of functional imaging in the management of lymphoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Riemer H. J. A. Slart,et al.  Imaging Techniques in Nuclear Cardiology for the Assessment of Myocardial Viability , 2005, The International Journal of Cardiovascular Imaging.

[14]  Walter R Wilson,et al.  Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. , 2010, Circulation.

[15]  O. Schober,et al.  Therapy monitoring in aspergillosis using F-18 FDG positron emission tomography. , 2001, Clinical nuclear medicine.

[16]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[17]  R. Boellaard,et al.  Quantitative Analysis of Response to Treatment with Erlotinib in Advanced Non–Small Cell Lung Cancer Using 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET , 2011, The Journal of Nuclear Medicine.

[18]  A. Alavi,et al.  Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions. , 2009, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[19]  M. Mehta,et al.  Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.

[20]  A. Alavi,et al.  Assessing global cardiovascular molecular calcification with 18F-fluoride PET/CT: will this become a clinical reality and a challenge to CT calcification scoring? , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  R. Nicholson,et al.  EGFR and cancer prognosis. , 2001, European journal of cancer.

[22]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[23]  Abass Alavi,et al.  Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  M. Gregianin,et al.  Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  M. Majmudar,et al.  Cardiovascular Molecular Imaging: The Road Ahead , 2012, The Journal of Nuclear Medicine.

[26]  Giovanni Paganelli,et al.  68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors , 2010, Journal of Nuclear Medicine.

[27]  Leopold Stiebellehner,et al.  What every radiologist should know about idiopathic interstitial pneumonias. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[28]  B. Barlogie,et al.  Diagnosis of infection of implantable central venous catheters by [18F]fluorodeoxyglucose positron emission tomography , 2004, Nuclear medicine communications.

[29]  A. Alavi,et al.  Potential of Dual Time Point FDG-PET Imaging in Differentiating Malignant from Benign Pleural Disease , 2009, Molecular Imaging and Biology.

[30]  A. Alavi,et al.  Imaging with (18)F-FDG-PET in infective endocarditis: promising role in difficult diagnosis and treatment monitoring. , 2009, Hellenic journal of nuclear medicine.

[31]  G. Hortobagyi,et al.  FDG-PET/CT compared with conventional imaging in the detection of distant metastases of primary breast cancer. , 2011, The oncologist.

[32]  A. Sodickson,et al.  Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. , 2009, Radiology.

[33]  Abass Alavi,et al.  Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  Thomas Beyer,et al.  Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  I. Apostolova,et al.  Correlation of Inflammation Assessed by 18F-FDG PET, Active Mineral Deposition Assessed by 18F-Fluoride PET, and Vascular Calcification in Atherosclerotic Plaque: A Dual-Tracer PET/CT Study , 2011, The Journal of Nuclear Medicine.

[36]  Eric C Ford,et al.  Comparison of FDG-PET/CT and CT for delineation of lumpectomy cavity for partial breast irradiation. , 2008, International journal of radiation oncology, biology, physics.

[37]  Ora Israel,et al.  Cancer Recurrence: Diagnostic Value and Impact on Patient Management , 2004 .

[38]  P. Lambin,et al.  Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  E. Parra,et al.  Collagen V-induced nasal tolerance downregulates pulmonary collagen mRNA gene and TGF-beta expression in experimental systemic sclerosis , 2010, Respiratory research.

[40]  D. Groheux,et al.  The Yield of 18F-FDG PET/CT in Patients with Clinical Stage IIA, IIB, or IIIA Breast Cancer: A Prospective Study , 2011, The Journal of Nuclear Medicine.

[41]  C. Rübe,et al.  Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  T. Nakajima,et al.  Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma. , 2012, European journal of cancer.

[43]  M. Kell,et al.  FDG-PET/CT in the staging of local/regional metastases in breast cancer. , 2011, Breast.

[44]  R. Coleman,et al.  Recommendations on the Use of 18F-FDG PET in Oncology , 2008, Journal of Nuclear Medicine.

[45]  A. Margulis.  Molecular imaging: love it or lose it. , 2012, Radiology.

[46]  A. Alavi,et al.  Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[47]  Yiyan Liu.  Characterization of thymic lesions with F-18 FDG PET-CT: an emphasis on epithelial tumors , 2011, Nuclear medicine communications.

[48]  Raffaele Pezzilli,et al.  Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors , 2010, Journal of Nuclear Medicine.

[49]  Samuel Z Goldhaber,et al.  Pulmonary embolism and deep vein thrombosis , 2012, The Lancet.

[50]  A. Alavi,et al.  Diagnostic Performance of FDG-PET, MRI, and Plain Film Radiography (PFR) for the Diagnosis of Osteomyelitis in the Diabetic Foot , 2010, Molecular Imaging and Biology.

[51]  H. Biersack,et al.  Impact of Dual-Time-Point F-18 FDG PET/CT in the Assessment of Pleural Effusion in Patients With Non-Small-Cell Lung Cancer , 2011, Clinical nuclear medicine.

[52]  J. Cockcroft,et al.  Excessive Aortic Inflammation in Chronic Obstructive Pulmonary Disease: An 18F-FDG PET Pilot Study , 2010, The Journal of Nuclear Medicine.

[53]  Kyung Soo Lee,et al.  Pneumoconiosis: Comparison of Imaging and Pathologic Findings , 2006 .

[54]  I. Nault,et al.  Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. , 2012, Journal of the American College of Cardiology.

[55]  C. Nanni,et al.  Gallium-labelled peptides for imaging of inflammation , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[56]  A. Alavi,et al.  A new dimension of FDG-PET interpretation: assessment of tumor biology , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[57]  Maria Grazia Bongiorni,et al.  Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). , 2009, Heart rhythm.

[58]  Nan-Tsing Chiu,et al.  Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer. , 2012, Radiology.

[59]  Rakesh Kumar,et al.  Imaging thrombus in cancer patients with FDG PET–CT , 2012, Japanese Journal of Radiology.

[60]  Sameer Bansilal,et al.  Atherosclerosis Inflammation Imaging with 18F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations , 2008, Journal of Nuclear Medicine.

[61]  H. Groen,et al.  Preoperative staging of non-small-cell lung cancer with positron-emission tomography. , 2000, The New England journal of medicine.

[62]  Yiyan Liu.  Demonstrations of AIDS-associated malignancies and infections at FDG PET-CT , 2011, Annals of nuclear medicine.

[63]  Arfa R. Khan,et al.  ACR Appropriateness Criteria on solitary pulmonary nodule. , 2007, Journal of the American College of Radiology : JACR.

[64]  W. Oyen,et al.  18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[65]  D. Miglioretti,et al.  Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. , 2009, Archives of internal medicine.

[66]  A. G. Vicente,et al.  Análisis de costo-efectividad en el diagnóstico de fiebre de origen desconocido y el papel de la 18F-FDG PET-TC: propuesta de algoritmo diagnóstico , 2012 .

[67]  James A Scott,et al.  18F-FDG PET of pulmonary embolism. , 2007, AJR. American journal of roentgenology.

[68]  Klemens Scheidhauer,et al.  Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  L. Sequist,et al.  Timing of epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung cancer with EGFR mutations. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  Tatsuya Ohno,et al.  Use of FDG-PET in Radiation Treatment Planning for Thoracic Cancers , 2012, International journal of molecular imaging.

[71]  W. Woodward,et al.  Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs. , 2012, International journal of radiation oncology, biology, physics.

[72]  W. Yang,et al.  False-positive lesions mimicking breast cancer on FDG PET and PET/CT. , 2012, AJR. American journal of roentgenology.

[73]  Tae Hoon Kim,et al.  18F-FDG PET imaging of progressive massive fibrosis , 2010, Annals of nuclear medicine.

[74]  A. Alavi,et al.  Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. , 2011, Archives of dermatology.

[75]  Hiroshi Fukuda,et al.  Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey , 2007, Annals of nuclear medicine.

[76]  Abass Alavi,et al.  Impact of dual-time-point 18F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[77]  J. Luketich,et al.  Fluorine-18-fluorodeoxyglucose uptake in pneumonia. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[78]  W. Wuyts,et al.  Clinical use of biomarkers of survival in pulmonary fibrosis , 2010, Respiratory research.

[79]  Y. Erdi,et al.  Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  M. Conti.  Focus on time-of-flight PET: the benefits of improved time resolution , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[81]  Shu-ye Yang,et al.  A meta-analysis of fluorodeoxyglucose-positron emission tomography versus scintigraphy in the evaluation of suspected osteomyelitis , 2011, Nuclear medicine communications.

[82]  A. Alavi,et al.  Non-FDG PET in the practice of oncology. , 2010, Indian journal of cancer.

[83]  David A Lynch,et al.  Idiopathic interstitial pneumonias: CT features. , 2005, Radiology.

[84]  A. Kilicgun,et al.  Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer , 2012, Medical Oncology.

[85]  G. Gladish,et al.  Large Decreases in Standardized Uptake Values After Definitive Radiation Are Associated with Better Survival of Patients with Locally Advanced Non–Small Cell Lung Cancer , 2012, The Journal of Nuclear Medicine.

[86]  Hiroshi Fukuda,et al.  Radiation exposure and risk–benefit analysis in cancer screening using FDG-PET: results of a Japanese nationwide survey , 2011, Annals of nuclear medicine.

[87]  A. Alavi,et al.  PET Assessment of Brown Fat. , 2011, PET Clinics.

[88]  M. Tucci,et al.  Assessment of lung inflammation with 18F-FDG PET during acute lung injury. , 2010, AJR. American journal of roentgenology.

[89]  Yen-Wen Wu,et al.  Using 18-fluoro-2-deoxyglucose positron emission tomography in detecting infectious endocarditis/endoarteritis: a preliminary report. , 2004, Academic radiology.

[90]  Yukiko Nakamura,et al.  18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors , 2011, Annals of nuclear medicine.

[91]  A. Alavi,et al.  FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[92]  R. Coleman,et al.  Relationship Between Cancer Type and Impact of PET and PET/CT on Intended Management: Findings of the National Oncologic PET Registry , 2008, Journal of Nuclear Medicine.

[93]  R. Boellaard,et al.  Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[94]  A. Marx,et al.  New WHO histologic classification predicts prognosis of thymic epithelial tumors , 2002, Cancer.

[95]  M. Osman,et al.  Does 18F-FDG Uptake by Respiratory Muscles on PET/CT Correlate with Chronic Obstructive Pulmonary Disease? , 2011, The Journal of Nuclear Medicine Technology.

[96]  Robert A. deKemp,et al.  The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience , 2012, The Journal of Nuclear Medicine.

[97]  Ursula Nestle,et al.  Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[98]  H. Schirrmeister,et al.  Pericystic metabolic activity in alveolar echinococcosis: assessment and follow-up by positron emission tomography. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[99]  T. Franquet,et al.  [Idiopathic interstitial pneumonias]. , 2012, Radiologia.

[100]  K. Alkattan,et al.  Clinical use of combined positron emission tomography and computed tomography in thymoma recurrence. , 2010, Interactive cardiovascular and thoracic surgery.

[101]  M. Mohty,et al.  Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[102]  Shalini K Vinod,et al.  Diagnostic and staging impact of radiotherapy planning FDG-PET-CT in non-small-cell lung cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[103]  R. Bale,et al.  68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT , 2007, Journal of Nuclear Medicine.

[104]  G. Musch,et al.  Spatial Heterogeneity of Lung Perfusion Assessed with 13N PET as a Vascular Biomarker in Chronic Obstructive Pulmonary Disease , 2010, Journal of Nuclear Medicine.

[105]  David A Mankoff,et al.  FDG PET, PET/CT, and breast cancer imaging. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[106]  B. Spiegelman,et al.  Transcriptional control of brown fat development. , 2010, Cell metabolism.

[107]  Mannudeep K. Kalra,et al.  Comparison of Hybrid and Pure Iterative Reconstruction Techniques With Conventional Filtered Back Projection: Dose Reduction Potential in the Abdomen , 2012, Journal of computer assisted tomography.

[108]  Baosheng Li,et al.  Standard uptake value and metabolic tumor volume of 18F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[109]  N. Sunaga,et al.  The role of [18F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors , 2011, Cancer imaging : the official publication of the International Cancer Imaging Society.

[110]  J. Le Heuzey,et al.  Whole body [(18) F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[111]  S. Johnston,et al.  Positron emission tomography/computed tomography in the management of recurrent/metastatic breast cancer: a large retrospective study from the Royal Marsden Hospital. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[112]  H. Kindler,et al.  Update on malignant pleural mesothelioma. , 2011, Seminars in respiratory and critical care medicine.

[113]  D. Schuster,et al.  Positron emission tomography with [18F]fluorodeoxyglucose to evaluate neutrophil kinetics during acute lung injury. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[114]  R. Hicks.  Role of 18F-FDG PET in Assessment of Response in Non–Small Cell Lung Cancer , 2009, Journal of Nuclear Medicine.

[115]  Z. Keidar,et al.  Fever of Unknown Origin: The Role of 18F-FDG PET/CT , 2008, Journal of Nuclear Medicine.

[116]  Matthias Reimold,et al.  Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[117]  B. Barlogie,et al.  18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[118]  A. Alavi,et al.  Avid FDG uptake in the right ventricle coupled with enhanced intercostal muscle hypermetabolism in pneumoconiosis. , 2007, Clinical nuclear medicine.

[119]  D. Postma,et al.  Chronic obstructive pulmonary disease. , 2002, Clinical evidence.

[120]  A. Alavi,et al.  Current Evidence Base of FDG-PET/CT Imaging in the Clinical Management of Malignant Pleural Mesothelioma: Emerging Significance of Image Segmentation and Global Disease Assessment , 2011, Molecular Imaging and Biology.

[121]  A. Groves,et al.  Idiopathic Pulmonary Fibrosis and Diffuse Parenchymal Lung Disease: Implications from Initial Experience with 18F-FDG PET/CT , 2009, Journal of Nuclear Medicine.

[122]  A. Al-Amro,et al.  F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection. , 2000, Clinical nuclear medicine.

[123]  Sanjiv S Gambhir,et al.  Molecular imaging techniques in body imaging. , 2007, Radiology.

[124]  Z. Keidar,et al.  FDG PET/CT imaging in the diagnosis of osteomyelitis in the diabetic foot , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[125]  B. Kim,et al.  Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer , 2012, Annals of Nuclear Medicine.

[126]  C. Faivre-Finn,et al.  The role of positron emission tomography in management of small cell lung cancer. , 2011, Lung cancer.

[127]  P. Veit-Haibach,et al.  Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[128]  Marc Kachelriess,et al.  Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[129]  A. Alavi,et al.  Detection and Quantification of Molecular Calcification by PET/Computed Tomography: A New Paradigm in Assessing Atherosclerosis. , 2011, PET clinics.

[130]  N. Morrell,et al.  In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma , 2003, European Respiratory Journal.

[131]  R. Boellaard,et al.  Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[132]  C. Gamez,et al.  Molecular imaging in sarcoidosis , 2011, Current opinion in pulmonary medicine.

[133]  H. Tonami,et al.  Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[134]  W. Oyen,et al.  FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[135]  W. Oyen,et al.  Cost-Effectiveness of Routine 18F-FDG PET/CT in High-Risk Patients with Gram-Positive Bacteremia , 2011, The Journal of Nuclear Medicine.

[136]  R. Port,et al.  18F-FDG PET as a Surrogate Biomarker in Non–Small Cell Lung Cancer Treated with Erlotinib: Newly Identified Lesions Are More Informative Than Standardized Uptake Value , 2012, The Journal of Nuclear Medicine.

[137]  B. Cheson,et al.  The role of FDG-PET scans in patients with lymphoma. , 2007, Blood.

[138]  F Doucet-Populaire,et al.  (18)F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[139]  R. Wahl,et al.  Diagnosis and Differentiation of Bronchioloalveolar Carcinoma from Adenocarcinoma with Bronchioloalveolar Components with Metabolic and Anatomic Characteristics Using PET/CT , 2008, Journal of Nuclear Medicine.

[140]  H. Tsuda,et al.  Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer. , 2008, Japanese journal of clinical oncology.

[141]  D. Dey,et al.  Coronary Arterial 18F-FDG Uptake by Fusion of PET and Coronary CT Angiography at Sites of Percutaneous Stenting for Acute Myocardial Infarction and Stable Coronary Artery Disease , 2012, The Journal of Nuclear Medicine.

[142]  G. Vlastos,et al.  Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[143]  A. Alavi,et al.  Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[144]  B. Prendergast,et al.  Positron emission tomography (PET): a new tool in the diagnosis of endocarditis. , 2009, Heart.

[145]  Zhen Cheng,et al.  PET of EGFR Expression with an 18F-Labeled Affibody Molecule , 2012, The Journal of Nuclear Medicine.

[146]  Shu-ye Yang,et al.  A meta-analysis of the value of fluorodeoxyglucose-PET/PET-CT in the evaluation of fever of unknown origin. , 2011, European journal of radiology.

[147]  J. Min,et al.  Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[148]  A. Alavi,et al.  Detection by 18F-FDG-PET/CT of upper extremity acute deep venous thrombosis. , 2011, Hellenic journal of nuclear medicine.

[149]  K. Uematsu,et al.  Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma. , 2011, Oncology reports.

[150]  A. Alavi,et al.  Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck , 1999, European Journal of Nuclear Medicine.

[151]  D. Binns,et al.  Effect of PET/CT on Management of Patients with Non–Small Cell Lung Cancer: Results of a Prospective Study with 5-Year Survival Data , 2012, The Journal of Nuclear Medicine.

[152]  S. Pavlović,et al.  The Utility of 18F-FDG PET/CT for Diagnosis and Adjustment of Therapy in Patients with Active Chronic Sarcoidosis , 2012, The Journal of Nuclear Medicine.

[153]  E. Bensadoun,et al.  PET Imaging in Patients with Coal Workers Pneumoconiosis and Suspected Malignancy , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[154]  L. Voltolini,et al.  Iterative surgical resections for local recurrent and second primary bronchogenic carcinoma. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[155]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[156]  T. Werner,et al.  Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography/computed tomography--a novel concept. , 2011, Hellenic journal of nuclear medicine.

[157]  H. Scholten,et al.  The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis. , 2005, The Journal of bone and joint surgery. American volume.

[158]  E. V. van Beek,et al.  Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. , 2012, Journal of the American College of Cardiology.

[159]  A. Alavi,et al.  Deep venous thrombosis on F-18 FDG PET/CT imaging. , 2006, Clinical nuclear medicine.

[160]  H. Shim,et al.  Stroma Targeting Nuclear Imaging and Radiopharmaceuticals , 2012, International journal of molecular imaging.

[161]  Kyoungjune Pak,et al.  Predictive Value of F-18 FDG PET/CT for Malignant Pleural Effusion in Non-Small Cell Lung Cancer Patients , 2011, Oncology Research and Treatment.

[162]  S. A. Khonsary,et al.  Idiopathic Pulmonary Fibrosis: Evaluation with Positron Emission Tomography , 2006, Respiration.

[163]  Robert J. Gillies,et al.  Causes and Consequences of Increased Glucose Metabolism of Cancers , 2008, Journal of Nuclear Medicine.

[164]  A. G. García Vicente,et al.  [Analysis of cost-effectiveness in the diagnosis of fever of unknown origin and the role of (18)F-FDG PET-CT: a proposal of diagnostic algorithm]. , 2012, Revista espanola de medicina nuclear e imagen molecular.

[165]  Yalun Li,et al.  The value of 18F-FDG-PET/CT in the differential diagnosis of solitary pulmonary nodules in areas with a high incidence of tuberculosis , 2011, Annals of nuclear medicine.

[166]  D. Bailey,et al.  A retrospective evaluation of radiation dose associated with low dose FDG protocols in whole-body PET/CT , 2011, Australasian Physical & Engineering Sciences in Medicine.

[167]  S. Dadparvar,et al.  Association of vascular fluoride uptake with vascular calcification and coronary artery disease , 2012, Nuclear medicine communications.

[168]  R. Houot,et al.  Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[169]  Abass Alavi,et al.  Prognostic Implication of Dual-Phase PET in Adenocarcinoma of the Lung , 2010, Journal of Nuclear Medicine.

[170]  C. Haslett,et al.  In vivo measurement of neutrophil activity in experimental lung inflammation. , 1994, American journal of respiratory and critical care medicine.

[171]  Sang-We Kim,et al.  The Role of Integrated 18F-FDG PET-CT as a Staging Tool for Limited-Stage Small Cell Lung Cancer: A Retrospective Study , 2012, Oncology Research and Treatment.

[172]  A. Alavi,et al.  Demonstration of Excessive Metabolic Activity of Thoracic and Abdominal Muscles on FDG-PET in Patients With Chronic Obstructive Pulmonary Disease , 2005, Clinical nuclear medicine.

[173]  Pek-Lan Khong,et al.  Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. , 2009, Radiology.

[174]  D. Groheux,et al.  Triple-Negative Breast Cancer: Early Assessment with 18F-FDG PET/CT During Neoadjuvant Chemotherapy Identifies Patients Who Are Unlikely to Achieve a Pathologic Complete Response and Are at a High Risk of Early Relapse , 2012, The Journal of Nuclear Medicine.

[175]  Masaki Katsura,et al.  Model-based iterative reconstruction technique for radiation dose reduction in chest CT: comparison with the adaptive statistical iterative reconstruction technique , 2012, European Radiology.

[176]  Hisashi Adachi,et al.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[177]  T. Shiga,et al.  Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis , 2007, Annals of nuclear medicine.

[178]  R. Stockley,et al.  Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography. , 2012, American journal of respiratory and critical care medicine.

[179]  Ara Darzi,et al.  Preparing for precision medicine. , 2012, The New England journal of medicine.

[180]  Z. Win,et al.  FDG-PET imaging in Pneumocystis carinii pneumonia. , 2005, Clinical nuclear medicine.

[181]  Heoung Keun Kang,et al.  FDG PET/CT for the detection and evaluation of breast diseases: usefulness and limitations. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[182]  D K Owens,et al.  Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. , 2001, JAMA.

[183]  B. Hutton,et al.  18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[184]  M. Chiariello,et al.  Molecular imaging of atherosclerosis in translational medicine , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[185]  A. Alavi,et al.  Potential clinical utility of dual time point FDG-PET for distinguishing benign from malignant lesions: implications for oncological imaging. , 2009, Revista espanola de medicina nuclear.

[186]  G. Treglia,et al.  Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review. , 2011, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[187]  A. Alavi,et al.  Comparison of triple‐negative and estrogen receptor‐positive/progesterone receptor‐positive/HER2‐negative breast carcinoma using quantitative fluorine‐18 fluorodeoxyglucose/positron emission tomography imaging parameters , 2008, Cancer.

[188]  T. Derlin,et al.  Feasibility of 18F-Sodium Fluoride PET/CT for Imaging of Atherosclerotic Plaque , 2010, Journal of Nuclear Medicine.

[189]  Val J Lowe,et al.  A Comparison of the Diagnostic Accuracy of 18F-FDG PET and CT in the Characterization of Solitary Pulmonary Nodules , 2008, Journal of Nuclear Medicine.